GlassScriptPhysician profile
Renata Milman
NPI 1760779482
$9,771.59
in general payments reported to CMS, 2019-2025
47 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $644 · 2020: $587 · 2021: $2,726 · 2022: $1,768 · 2023: $1,300 · 2024: $1,468 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,915 · Entertainment: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,914.86 |
| Entertainment | $132.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,527.11 | 2019-2025 | Grafix Pl, Stravix Pl, Oasis Micro |
| Organogenesis INC. | $1,445.60 | 2019-2025 | Apligraf, Puraply Wound Matrix, Puraply |
| Liberty Surgical INC. | $1,200.00 | 2021 | |
| Abbvie INC. | $461.79 | 2021-2024 | |
| Kerecis Limited | $400.11 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $373.82 | 2019-2025 | Citrefix, Inbone, Ortholoc 3di Crosscheck |
| Ossio INC | $359.58 | 2022-2023 | |
| Convatec INC. | $304.22 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $274.29 | 2022-2025 | Nuzyra |
| In2bones USA, LLC | $262.56 | 2020-2022 | |
| Integra Lifesciences Corporation | $214.93 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Wright Medical Technology, INC. | $184.82 | 2019-2020 | |
| Nalu Medical, INC. | $179.87 | 2024 | Nalu Neurostimulation System |
| Reapplix INC. | $156.46 | 2022-2024 | 3c Patch Kit - Box |
| Musculoskeletal Transplant Foundation INC. | $132.10 | 2023 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renata Milman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.